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While iV-nitrosoethylmethylamine (NEMA) is carcinogenic
primarily for the liver, its /3-trideuterated derivative,
W-nitroso([2-Z)3]ethyl)methylaniine (NEMA-d3), also
produces a high incidence of tumors in the esophagus. To
determine whether this shift in organ specificity is associated
with an altered pattern of DNA alkylation, [methyl-14C]- and
[l-ethyl-14C]-labeled NEMA-d3 were administered to adult
male Fischer 344 rats as a single i.p. dose (0.05 mmol/kg;
4 h survival). Levels of methylated and ethylated purities in
the DNA of various organs were determined by radio-
chromatography on Sephasorb-HP columns. When compared
to previous data using undeuterated NEMA, 7-methylguanme
levels were found to be reduced by —30% in Hver and kidney,
but were 160% greater in esophagus. This resulted in a
decrease in the 7-methylguanine ratio for liver/esophagus
from 109 to 29. O*-Methylguanine was diminished in liver
and kidney, but levels in lung and esophagus were too low
for quantitative detection. Similarly, deuteration led to an
18% decrease of 7-ethylguanine in hepatic DNA. The observed
increase in esophageal DNA methylation correlates with the
increased carcinogenicity of NEMA-d3 relative to
undeuterated NEMA in that organ. Since pharmacokinetic
studies have shown that /3-trideuteration of NEMA does not
alter its bioavailability, the data suggest that the observed shift
in target organ results from isotopically-induced changes in
the balance among competing metabolic pathways in different
rat tissues.
Introduction
A'-Nitrosoethylmethylamine (NEMA*) is a powerful liver
carcinogen and of particular interest in mechanistic studies on
the organ specificity of nitrosamines since it does not follow the
general principle established by Druckrey and coworkers (1) that
asymmetric nitrosamines produce predominantly esophageal
tumors. Lijinsky et al. (2,3) have shown that deuteration of the
/3-carbon atom of NEMA leads to induction of esophageal
carcinomas in addition to liver tumors. A possible explanation
for this isotope effect on organ specificity is that the greater
effective strength of the C - D bond (relative to the C - H bond)
slows metabolic oxidation at the isotopically substituted
'Abbreviations: NEMA, N-rutrosoethylrnethylamine; NEMA-d3, A'-nitroso([2-
D3]ethyl)methylamine.
/3-position, shifting metabolism toward increasing a-hydroxyla-
tion of the ethyl group and causing correspondingly more
production of the powerfully alkylating methyldiazonium ion.
Since rat esophagus appears to be particularly vulnerable to die
carcinogenic effects of this methylating agent (4), the increased
potency of NEMA-d3 relative to NEMA in that organ would be
explained if die extent of this deuterium-induced metabolic
switching were sufficient to cause increased DNA mediylation
in me esophagus. We have previously shown that NEMA
mediylates, ethylates and 2-hydroxyediylates DNA of various
organs in the rat (4—6). To test whether (3-deuteration does cause
a shift in the profile of DNA adducts, we have now measured
the extent of DNA alkylation in various target and nontarget
organs of adult male Fischer 344 rats following exposure to single
doses of N-nitroso([2-D3]ethyl)methylamine (NEMA-d3)
14C-labeled in either the N-methyl or 1-ethyl position.
Materials and methods
Animals
Adult male Fischer 344 rats (120-150 g) were purchased from Charles River
Wiga GmbH, Sulzfeld, FRG. A standard laboratory diet and water were given
ad libitum.
Chemicals
[l-Ethyl-14C]-labeled NEMA-d3 was prepared as follows. Barium [uC)carbonate
(52.1 mCi/mmol, 2.04 mmol) was treated with 10 ml of concentrated sulfuric
acid and the liberated UCC>2 was condensed into a previously evacuated two-
neck flask cooled in liquid nitrogen. Anhydrous diethyl ether (5 ml) followed
by 4.49 ml of 0.454 M [D3]methyl magnesium iodide (2.04 mmol) in ether were
injected through a rubber septum onto the frozen 14CO2. The resulting mixture
was stirred for 1 h at -78°C and 10 min at room temperature, then evaporated
in vacua. The residual, doubly-labeled acetate salt was treated with 10 ml of
dichloromethane and 0.35 ml of 6 M hydrochloric acid. Water was removed from
the resulting labeled acetic acid solution by filtration through anhydrous magnesium
sulfate, rinsing with 15 ml of dichloromethane. The filtrate was mixed with
0.187 ml (2.2 mmol) of oxalyl chloride and refluxed for 2.5 h in a flask fitted
with a -78°C cc4d-finger condenser. The reaction mixture was cooled to -78°C
and a slow stream of methylaminc was bubbled through over a 30-min period
until the solution was basic to litmus. The resulting mixture was stirred at 25°C
for 30 min, filtered through Celite, and evaporated to dryness. The residual 602 mg
of crude, doubly-labeled N-methylacetamide was placed on a column of 5 g of
silica gel (70-230 mesh) packed in 95:5 ether:methanol and eluted with 60 ml
of the same solvent mixture followed by 45 ml of 90:10 ether: methanol to yield
68 mCiofthe amide on evaporation of the eluate. The labeled amide (1.38 mmol)
was taken up in 2 ml of dry tetrahydrofuran, added to a suspension of 134 mg
(3.53 mmol) of lithium aluminum hydride in tetrahydrofuran, refluxed for 1 h,
and cooled during the very slow addition of 4 ml of 80:20 tetrahydrofuran:water
followed by 4 ml of 5 M sodium hydroxide. The resulting mixture was distilled
into a receiver containing 1 ml of 3 M hydrochloric acid at 0°C, whereupon
3 ml of water was added to the distillation flask and the distillation was continued.
The distillate was rotary evaporated to remove organic solvent, mixed with 2 ml
of 3 M hydrochloric acid, and cooled in an ice bath. A solution of 2.86 g
(41.5 mmol) of sodium nitrite in 5 ml of water was dropped very slowly into
the doubly-labeled methylethylamine hydrcchloride in acid. After stirring in the
ice bath until addition was complete, the mixture was stirred for 3 min in a 30°C
bath and extracted with four 5-ml portions of dichlorometriane. The organic extracts
were dried over anhydrous magnesium sulfate, concentrated to 1 ml at 0°C on
a rotary evaporator, and eluted through a column of 1 g of silica gel with
dichloromethane to yield 46.6 mCi of nitrosamine (44% overall radiochemical
yield). Chromatography on a Waters RadialPak C18 column with 50:50
methanohwater at 0.6 ml/min eluted the nitrosamine at a retention time of 7.1 min.
Radioactivity detection indicated 100% radiochemical purity, while ultraviolet
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detection at 210 nm indicated 99% chemical purity. The ultraviolet spectrum in
water (absorbance maximum at 227 nm, extinction coefficient of 7781 1/mol/cm)
was similar to that of unlabeled NEMA. The mass spectrum was consistent with
the assigned structure and indicated an isotopic purity of 96.6% deuterium at
the 2-position.
[Methyl-14C]-labeled NEMA-d3 was synthesized as previously reported (7).
Its ultraviolet and chromatographic properties were similar to those for the
ethyl-labeled isomeT described in the previous paragraph (radiochemical purity,
98%; chemical purity, 99.5%; isotopic purity at the 2-position, 95.3% deuterium).
Nonradioactive NEMA-d3 was prepared by a procedure analogous to those
described above, as outlined in the following equation:
UAIH4 HONO
CDj-CO-Cl + CHj-NH, - CD,-CO-NH-CH, - CDj-CH,-NH-CH, - CT>,-CHJ-N(CHJ)-N . 0
It was purified by distillation at 74-75°C (34 mm Hg), showing ultraviolet
maxima in water of 228 nm (7888 1/mol/cm) and 334 nm (84 1/moL/cm), and
gave a high pressure liquid chromatogram indicating a chemical purity of 99.3%.
The mass spectrum revealed molecular ions at mil 91, 90, 89 and 88 atomic
mass units of relative intensities 90, 9, 1 and 0 respectively, pointing to an isotopic
purity at the 2-position of 96.3% deuterium.
For DNA alkylation studies, the radiolabeled compounds were used at sp.
act. of 10.7 and 48 mCi/mmol for [methyl-l4C]NEMA-d3 and [l-ethyl-l4C]-
NEMA-d3 respectively. For metabolism experiments, the sp. act. of [methyl-
MC]NEMA-d3 was adjusted to 1.83 mCi/mmol. The radiochemical purities
were checked immediately before use by HPLC on an RP 18 column (Shan-
don, ODS Hypersil, 4.6 X 250 mm) eluted with 10% aqueous methanol (v/v)
and were found to be >98%. Riatron scintillation cocktail was from Kontron
AG (Zurich, Switzerland) and Lumagel SB scintillation cocktail was from
Lumac/3M bv (Schaesberg, Netherlands). Sephasorb-HP was purchased from
Pharmacia Fine Chemicals (Uppsala, Sweden) and hydroxylapatite was from
Boehringer Mannheim GmbH, FRG. All other chemicals were of analytical
grade purity or higher.
Metabolic Cage
Two rats were given a single i.p. injection of [methyl-14C]NEMA-d3 at a dose
of 4.4 mg/kg (1.83 mCi/mmol) and monitored for 14 h in a metabolic cage
(Jencons Metabowl, Hemel Hempstead, United Kingdom) for expiration of
I4CO2, which was followed by collecting aliquots from two serially-connected
Nilox columns containing 1 N NaOH. Samples (0.5 ml) from the Nilox columns
were counted for radioactivity after the addition of 1.5 ml of water and 8 ml
of Lumagel SB (85% counting efficiency).
DNA alkylation by NEMA-d3 in vivo
Rats were given [methyl-14C]-labeled NEMA-d3 (4.4 mg/kg, 10.7 mCi/mmol,
eight animals) or [l-ethyl-14C]-labeled NEMA-dj (4.4 mg/kg, 48 mCi/mmol,
seven animals) as single i.p. doses and killed 4 h later. Organs were rapidly
removed, immediately frozen in liquid nitrogen and stored at -70°C.
DNA was isolated by phenol extraction of proteins and adsorption onto
hydroxylapatite as previously described (4). The DNA from 1 —2 g of tissue was
depurinated in 0.1 N HC1 for 20 h at 37°C. The hydrolysate was loaded onto
a Sephasorb column (1 x 50 cm) and eluted with 10 mM phosphate buffer (pH 5.5)
at a flow rate of 1.6 ml/min as described earlier (8). Adenine and guanine were
quantified by their absorption at 260 nm and I4C radioactivity was determined
by liquid scintillation counting (counting efficiency 85%). Concentrations of
methylated and ethylated purines were calculated assuming that their sp. act. was
identical to that of the nitrosamine injected. Analysis of hydroxyethylated DNA
adducts was performed using Bio-Rad AG 50W-X4 chromatography as previously
described (6,9).
Microsomal studies
To prepare the microsomes, hepatic tissue was obtained from 14 uninduced
8-week-old rats and homogenized in 0.15 M potassium chloride/0.2 M sucrose,
pH 7.4. This and all following steps were performed at 4°C. Pooled homogenate
was ccntrifuged at 9000 g for 20 min, then at 105 000 g for 75 min in an
ultracentrifuge. The resulting microsomal pellets were washed twice with potassium
chloride/sucrose, pooled, and resuspended in potassium chloride/sucrose solution
using a glass/glass tissue grinder. Individual aliquots were stored at -70°C. The
final protein concentration was determined using fluorescamine (10) to be
48 mg/ml, with bovine serum albumin used as the standard.
To follow the microsomal metabolism of NEMA and NEMA-d3, the method
of Farrelly et al. (11) was used. Reaction mixtures contained 0 - 1 0 m M
nitrosamine, 5 mM semicarbazide hydrochloride, 1 mM EDTA, 5 mM
glucose-6-phosphate, 1 mM NADP, 50 mM Tris, 1.6 mg of microsomal protein,
and 0.4 units of glucose-6-phosphate dehydrogenase in a total volume of 2 ml,
pH 8.0, 37°C. Reactions were started by mixing the nitrosamine with the other
reactants in 25-ml Erlenmeyer flasks, and were stopped after 20 min by addition
of 1 ml each of zinc sulfate (5% solution) and barium hydroxide (4.5% solution).
Control incubations consisted of reactions performed in the absence of nitrosamine
or with boiled microsomes. The dinitrophenylhydrazine adducts were prepared
and assayed as described (11); the Jfm and VmMX values were derived from the
data as previously indicated (11).
Results
The rate of metabolism of [methyl-l4C]NEMA-d3 was deter-
mined by monitoring exhaled CO2 following a dose of
4.4 mg/kg. Forty-eight percent of the administered radioactivity
was exhaled as 14CO2 over a 14-h period. The time at which
half the maximal amount of 14CO2 was exhaled was 1.4 h. After
~ 8 h the levels of expired radioactivity plateaued at a value 48%
of the administered dose. As this rate of metabolism was
comparable to that observed for metabolism of undeuterated
NEMA (5), the same survival time (4 h) was used for DNA
alkylation studies.
Sephasorb-HP radiochromatography of hydrolyzed DNA
revealed that C^-methylguanine and 7-methylguanine were the
major alkylated purines in all organs examined from [methyl-
l4C]NEMA-d3-treated animals and that C^-ethylguanine and
7-ethylguanine were the major radioactive peaks in chromato-
grams from [l-ethyl-l4C]NEMA-d3-treated animals. An early
peak which eluted between pyrimidines (in breakthrough fraction)
and 7-ethylguanine was observed in hepatic DNA from animals
receiving [1-ethyl-14C]NEMA-d3. Subsequent chromatography
using Bio-Rad AG 50W-X4 (which is capable of resolving
3-ethyladenine and 7-hydroxyethylguaru'ne) suggested that this
peak was most likely 3-ethyladenine (data not shown). No
hydroxyethylated purines could be detected using this latter
chromatographic system.
The extent of DNA alkylation in liver, kidney, lung and
esophagus by NEMA-d3 14C-labeled in either the A'-methyl or
1-ethyl position is shown in Table I. The results obtained from
previous experiments with non-deuterated NEMA (5) are
presented for comparison. The administration of [methyl-14C]-
NEMA-d3 resulted in -30% less DNA methylation in liver and
kidney (as measured by either Cfi- or 7-methylguanine levels)
relative to the amount of methylation produced by non-deuterated
[methyl-l4C]NEMA. In contrast, 7-methylation of esophageal
DNA was -2 .6 times as great in animals receiving [methyl-
l4C]NEMA-d3 compared to animals receiving non-deuterated
[methyl-14C]NEMA. The overall inter-organ shift in DNA
methylation is best demonstrated by the liver/esophagus
7-methylguanine ratio (Table I). This value decreased from 109
(obtained using non-deuterated [methyl-14C]NEMA) to 29
(using [methyl- C]NEMA-d3). In lung, 7-methylguanine levels
were comparable in animals treated with [methyl- C]NEMA-d3
and [methyl-14C]NEMA.
The amount of 7-ethylguanine formed in hepatic DNA appeared
to be slightly less in animals treated with [l-ethyl-14C]NEMA-d3
compared to those treated with undeuterated [l-ethyl-l4C]-
NEMA, slightly higher in kidney, and approximately double in
lung. This resulted in a decrease in the liver/lung 7-ethylguanine
ratio from 20, using undeuterated [l-ethyl-l4C]NEMA, to 8.2
using [l-ethyl-l4C]NEMA-d3. Ethylation of esophageal DNA,
however, could not be detected after treatment with either
[l-ethyl-14C]NEMA or [l-ethyl-l4C]NEMA-d3.
To directly compare the ratio of methylation to ethylation by
NEMA-d3 and NEMA, the 7-methylguanine/7-ethylguanine
ratio has been included in Table I. This ratio is slightly lower
(by 17%) for liver using NEMA-d3 and dramatically lower (by
40-50%) for kidney and lung, indicating that there is propor-
tionately more ethylation (and/or less methylation) in these tissues
for deuterated than for non-deuterated NEMA.
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Table I. Comparison of DNA
Liver
7-alkG
C^-alkG
(/-allcG^-alkC1
7-meG/7-etG
O^-meG/cAetG
Kidney
7-alkG
(/-alkG
Cfi-alkGn-aikG1
7-meG/7-etG
(AmeG/C^-etG
Esophagus
7-alkG
Lung
7-alkG
(/-alkG
C^-alkGH-alkG
7-meG/7-etG
7-alkG ratios
Liver/kidney
Liver/esophagus
Liver/lung
alkylation by NEMA and
NEMAb
[methyl-14C]
1014 ± 71
103 ± 10
0.10 ± 0.01
73 ± 3
4.0 ± 0.5
0.055 ± 0.007
9.3
3.8 ± 0.3
n.d.
-
14
109
267
NEMA-dj
169
29
183
-
13
in the organs of Fischer
[l-«hyl-14C]
6.0 ± 0.4
3.5 ± 0.5
0.58 ± 0.09
0.4
n.d.
-
n.d.
0.3
n.d.
-
15
-
20
344 rats'
NEMA-d-,c
[methyl-l4C]
690 ± 49
71 ± 7
0.10 ± 0.01
48 ± 5
2.8 ± 0.4
0.058 ± 0.010
24
3.9 ± 0.1
n.d.
-
14
29
177
141
30
107
20
6.5
[l-ethyl-l4C]
4.9 ± 0.2
2.4 ± 0.1
0.49 ± 0.03
0.45 ± 0.03
0.14 ± 0
0.31 ± 0.02
n.d.
0.6
0.08
0.13
11
-
8.2
•Male Fischer 344 rats received a single i.p. dose (4.4 mg/kg) of [methyl- 14C]NEMA, [l-ethyl-l4C]NEMA, [methyl-14C]NEMA-d3, or
[l-ethyl-14C]NEMA-d3 and were killed 4 h later. Alkylated purines are expressed as junol/mol guarune. Abbreviations: 7-alkG, 7-alkylguanine; O'-alkG,
(Aalkylguanine; 7-meG, 7-methylguanine; 7-etG, 7-ethylguanine; C^-meG, 06-methylguanine; C^-etG, C^-ethylguanine; n.d., not detected.
"TData from von Hofe et al. (5), means ± SD of three determinations for liver, two for methylation values in kidney and lung, and single analyses of
pooled samples for ethylation in the latter two organs plus methylation in the esophagus.
cMeans of three determinations ± SD for liver alkylation and kidney methylation or two replicates for renal etbylation and lung methylation. Esophagus
data and those for lung ethylation are from single analyses of pooled tissue DNA.
dRatios of C^-alkG to 7-alkG values ± SD.
For comparison with the in vivo alkylation data, the microsomal
metabolism of the two nitrosamines was also studied. Kinetic
constants for their conversion to the two a-hydroxylation
products, acetaldehyde and formaldehyde, by uninduced liver
microsomes are summarized in Table II. As was found for the
rates of in vivo clearance of NEMA (7), no significant change
in Km or VW3X values could be observed on /3-deuteration of the
carcinogen.
Discussion
The finding of Lijinsky et al. (2) that j3-trideuteration of NEMA
converts it from a liver-specific carcinogen to one with additional
activity in esophagus offers an unusual opportunity to probe the
mechanism of organotropism for a simple yV-nitroso compound.
We originally speculated that this shift toward the esophagus
resulted from an isotopically-induced retardation of /3-hydroxyla-
tion during the first pass through the liver following absorption
from the gut of the orally-administered carcinogen, but this
proved to be incorrect. Detailed pharmacokinetic studies failed
to detect any difference between NEMA and NEMA-d3 in
bioavailability or any other pharmacokinetic parameter, nor was
any of the /S-hydroxylation product, N-nitrosomethyl^-hydroxy-
ethyl)amine, found in the blood at a detection limit corresponding
to 0.3% of the dose (7). Also, the organotropic shift could not
Table D. Kinetic parameters for metabolism
rat liver microsomes*
Metabolite A ,^ (mM)
NEMA
Acetaldehyde 1.41 ± 0.29
Formaldehyde 7.25 ± 5.46
NEW
1.48
5.02
!A-d3
± 0.08
± 4.51
of NEMA and NEMA-d3
V,^ (nmol/min/mg of
protein)
NEMA
4.44 ±
1.50 ±
by
NEMA-d3
1.22 4.61 ±
0.98 1.49 ±
1.69
0.46
•Means ± SD of six (NEMA) or four (NEMA-dj) determinations.
be ascribed to altered excretion of unchanged nitrosamine, as
neither NEMA nor NEMA-d3 could be found in the urine at a
level of 0.03% of the dose (7).
Rather, the present results suggest that the observed organo-
tropic shift is attributable to a different sort of metabolic
switching. It has already been shown that a-deuteration of simple
nitrosamines such as NEMA (11) and A^-nitrosodimethylamine
(12,13) can retard metabolism at the deuterium-substituted
position, and one might expect deuteration of the /3-carbon to
result in a similar retardation. Assuming that the ethyl group of
NEMA would normally be oxidized in esophagus at both the /3-
and a-carbons, retardation of /3-attack by the presence of
deuterium at that position could make cr-oxidation relatively more
extensive by default. This would lead in turn to more extensive
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alkylation of DNA at a given molar dose level and increased
carcinogenic potency. As predicted from this hypothetical
interpretation, the levels of guanine methylation in esophageal
DNA were more than doubled in animals receiving NEMA-d3
relative to those receiving NEMA, and the 7-methylguanine ratio
for liver/esophagus decreased four-fold (from 109 to 29).
Ethylation, however, still could not be detected in esophageal
DNA using NEMA-d3. These results are consistent with the
report that DNA methylation is of primary importance in the
induction of esophageal neoplasms by methylalkylnitrosamines
(4), and we conclude that the postulated metabolic switching
mechanism offers a reasonable explanation for the relatively great
carcinogenic potency of NEMA-d3 in rat esophagus.
The fact that increased methylation is observed only in the
esophagus suggests that other organs strike a different balance
among the various possible competing pathways of NEMA
metabolism. For example, the lower methylation (but not
ethylation) of kidney DNA by NEMA-d3 compared to NEMA
suggests that one or more metabolic pathways in that organ are
responsible for /3-oxidizing NEMA to an alkylating agent capable
of methylating (but not ethylating) DNA. Again, /3-deuteration
would inhibit the formation of this species, giving rise to
diminished quantities of 7- and 0*-methylguanine (Table I). As
to the identity of such an alternate methylating agent, a plausible
candidate has recently been suggested (14). Attachment of
substituents that are easily displaced by nucleophiles at the
/3-position of NEMA is known to activate it toward intramolecular
attack on the nitrosamino group to produce the 3-methyl-4,5-
dihydro-l,2,3-oxadiazolium ion (15). This highly polar species
is a direct-acting mutagen (16) and methylating agent (17) whose
formation from NEMA via the net insertion of a sulfate ester
function (14—20) or similar leaving group at the /3-carbon can
easily be envisioned. Formation of this intermediate should be
hindered by the presence of deuterium at the /3-position of
NEMA, thereby reducing the level of DNA methylation.
Ethylation, on the other hand, cannot occur by a /3-oxidation
mechanism and therefore should not be greatly affected by
deuteration at the /3-position. It is noteworthy that coadministra-
tion of ethanol with NEMA results in a shift in DNA adduct
formation (5) similar to that observed for NEMA-d3, suggesting
that ethanol may also preferentially inhibit reactions at the
/3-position of NEMA in kidney.
The similarity of the lung alkylation data for NEMA relative
to NEMA-d3 (Table I) suggests that the cytochrome P450
isozymes primarily responsible for NEMA metabolism in that
organ are not greatly influenced by deuterium substitution at the
/3-carbon; here again, the result with deuteration mimics that seen
previously on ethanol coadministration (5). As for the liver, the
lower alkylation levels with NEMA-d3 might have been
expected to correlate with weaker carcinogenic effects; the fact
that it was at least as active as NEMA in the chronic administra-
tion studies (2) may only reflect their similar positions on the
high-dose plateau of the dose—response curve.
In conclusion, the present results show that the high incidence
of esophageal tumors observed with NEMA-d3 is paralleled by
an inter-organ shift of DNA methylation from liver to esophagus.
This is consistent with previous studies (4) suggesting that
methylation of esophageal DNA is a critical determinant of that
organ's susceptibility to carcinogenesis by nitrosamines. It is not
yet clear how /S-trideuteration of NEMA causes this inter-organ
shift in DNA alkylation, though presumably decreased metabol-
ism at the /3-carbon (due to the increased strength of the C - D
bond) must play a role. Pharmacokinetic differences between
NEMA and NEMA-d3 have been ruled out (7), as have
differences in microsomal metabolism, at least for the liver (Table
H). This would support the hypothesis that in esophagus the
inhibition of metabolism by deuterium at the /3-position results
in a switching toward increased hydroxylation at the a-methylene
carbon which subsequently results in more DNA methylation.
The data further suggest that in organs where /3-trideuteration
of NEMA results in decreased DNA methylation (e.g. kidney),
metabolism at the /3-position of NEMA may result in a polar
intermediate which is capable of methylating but not ethylating
renal DNA. Further studies are required to determine if these
hypotheses are correct or whether other mechanisms are
responsible for the inter-organ shift in NEMA metabolism
resulting from /3-deuteration of this carcinogen.
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